Superpower Sells Peptides Following Looser Oversight
San Francisco startup Superpower, led by cofounder Max Marchione, is selling legally available peptides and subscription biomarker testing to members as of January 2024. The company expects its offerings to expand as federal oversight loosens, citing Health and Human Services secretary Robert F. Kennedy Jr.'s February announcement to remove restrictions on 14 peptides. Investors and telehealth firms are professionalizing peptide access, signaling potential mainstream consumer market growth.
Key Points
- 1Superpower sells legal peptides and subscription biomarker testing to wellness-focused consumers
- 2Highlights regulatory shifts including RFK Jr.'s February pledge to remove FDA peptide restrictions
- 3Signals commercialization and mainstreaming potential, prompting telehealth, manufacturing, and concierge medicine opportunities
Scoring Rationale
Solid industry reporting and notable policy mention, but limited novelty and low relevance to core data-science audiences.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems